White matter mapping in Alzheimer's disease: A neuropathological study

White matter disease (WMD) with pervasive non-focal subtotal tissue loss is frequently seen in Alzheimer's disease (AD) upon neuropathological examination. Although WMD has varying effects on AD symptoms, accurate clinical detection is difficult due partly to scarcity of correlative structural imaging and histopathological studies. Neuropathological studies of WMD severity and distribution have been conducted earlier using semi-quantitative methods. A technique for quantifying WMD objectively in large white matter areas, based on optical density (OD) measurements on images of scanned whole-brain sections, was developed and was validated using conventional microscopic assessment. Altogether, 16 AD cases with concomitant WMD (AD-WMD) and 9 cases of AD without WMD (AD-only) were analysed. The OD values correlated significantly with the neuropathological severity of WMD and were significantly lower in AD-WMD than in AD-only in frontal, frontoparietal, temporal and parietal white matter but not in the occipital white matter, the frontal OD difference being greatest. Useful baseline information on WMD distribution in AD to relate to in vivo imaging results was obtained.

[1]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[2]  D. Bennett,et al.  Clinical correlates of high signal lesions on magnetic resonance imaging in Alzheimer's disease , 1992, Journal of Neurology.

[3]  E. Larsson,et al.  Diffusion tensor MRI post mortem demonstrated cerebral white matter pathology , 2004, Journal of Neurology.

[4]  A. Brun,et al.  A white‐matter disease in dementia of Alzheimer's type – clinical and neuropathological correlates , 1989 .

[5]  E. Englund,et al.  Glial levels determine severity of white matter disease in Alzheimer's disease: a neuropathological study of glial changes , 2003, Neuropathology and applied neurobiology.

[6]  M. Filippi,et al.  White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging , 2002, Journal of neurology, neurosurgery, and psychiatry.

[7]  G. Bartzokis.  Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease , 2004, Neurobiology of Aging.

[8]  A. Brun,et al.  Subcortical pathology of Alzheimer's disease. , 1990, Advances in neurology.

[9]  K. Sturesson,et al.  Brain tissue microarrays in dementia research: White matter microvascular pathology in Alzheimer's disease , 2003, Neuropathology : official journal of the Japanese Society of Neuropathology.

[10]  L. Wahlund,et al.  White matter hyperintensities in dementia: does it matter? , 1994, Magnetic resonance imaging.

[11]  V. Hachinski,et al.  Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). , 1987, Archives of neurology.

[12]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[13]  Z. Khachaturian.  Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.

[14]  H. Möller,et al.  The case described by Alois Alzheimer in 1911 , 1998, European Archives of Psychiatry and Clinical Neuroscience.

[15]  J R Hodges,et al.  Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. , 2004, Journal of neurology, neurosurgery, and psychiatry.

[16]  P. Panegyres,et al.  Amyloid precursor protein gene isoforms in Alzheimer’s disease and other neurodegenerative disorders , 2000, Journal of the Neurological Sciences.

[17]  R. Shepherd,et al.  Functional and morphological response of the stria vascularis following a sensorineural hearing loss , 2002, Hearing Research.

[18]  T. Kurki,et al.  Clinical features of leuko-araiosis. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[19]  K. Blennow,et al.  Symptoms, Vascular Risk Factors and Blood-Brain Barrier Function in Relation to CT White-Matter Changes in Dementia , 2000, European Neurology.

[20]  F. Gunning-Dixon,et al.  The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. , 2000, Neuropsychology.

[21]  H S Markus,et al.  Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  A Brun,et al.  White matter changes in dementia of Alzheimer's type: the difference in vulnerability between cell compartments , 1990, Histopathology.

[23]  E. Londos,et al.  Clinical lewy body dementia and the impact of vascular components , 2000, International journal of geriatric psychiatry.

[24]  E. Englund,et al.  Cerebral Amyloid Angiopathy, White Matter Lesions and Alzheimer Encephalopathy – A Histopathological Assessment , 2002, Dementia and Geriatric Cognitive Disorders.

[25]  A. Brun,et al.  Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer's disease and in frontal lobe degeneration. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[26]  S. Berg,et al.  The influence of white matter lesions on neuropsychological functioning in demented and non‐demented 85‐year‐olds , 1996, Acta neurologica Scandinavica.

[27]  L Ketonen,et al.  Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease? , 1987, Journal of neurology, neurosurgery, and psychiatry.

[28]  J Shi,et al.  Relationships between arteriosclerosis, cerebral amyloid angiopathy and myelin loss from cerebral cortical white matter in Alzheimer's disease , 2004, Neuropathology and applied neurobiology.

[29]  Christine Fennema-Notestine,et al.  White matter mapping is needed , 2004, Neurobiology of Aging.

[30]  B. Corain.  Alzheimer's disease : advances in clinical and basic research , 1993 .

[31]  M. Noble.  The possible role of myelin destruction as a precipitating event in Alzheimer’s disease , 2004, Neurobiology of Aging.

[32]  A. Brun,et al.  A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.

[33]  T. Kurki,et al.  Relationship between vascular factors and white matter low attenuation of the brain , 1993, Acta neurologica Scandinavica.

[34]  L. Thal,et al.  Executive dysfunction in Alzheimer disease. , 2004, Archives of neurology.

[35]  C. Cotman,et al.  Oligodendrocyte degeneration in AD , 2004, Neurobiology of Aging.

[36]  A. Brun,et al.  Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading , 1981, Histopathology.

[37]  T. Erkinjuntti,et al.  CT in the differential diagnosis between Alzheimer's disease and vascular dementia , 1987, Acta neurologica Scandinavica.

[38]  F. Fazekas,et al.  The relation of cerebral magnetic resonance signal hyperintensities to Alzheimer's disease , 1996, Journal of the Neurological Sciences.

[39]  V. Hachinski,et al.  Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). , 1987, Archives of neurology.

[40]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[41]  O Almkvist,et al.  White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. , 1992, Archives of neurology.

[42]  Guo-Wei Li,et al.  Early protective effect of ischemic preconditioning on small intestinal graft in rats. , 2003, World journal of gastroenterology.

[43]  T. Erkinjuntti,et al.  White matter low attenuation on CT in Alzheimer's disease. , 1989, Archives of gerontology and geriatrics (Print).

[44]  K. Jellinger,et al.  The neuropathological diagnosis of Alzheimer disease. , 1998, Journal of neural transmission. Supplementum.